Llwytho...
Clinical utility of exemestane in the treatment of breast cancer
Breast cancer is the most prevalent cancer in women, causing a significant mortality worldwide. Different endocrine strategies are available for the treatment of hormone-sensitive breast cancer, including antiestrogen tamoxifen and fulvestrant, as well as third-generation aromatase inhibitors (AIs),...
Wedi'i Gadw mewn:
| Cyhoeddwyd yn: | Int J Womens Health |
|---|---|
| Prif Awduron: | , , , , , |
| Fformat: | Artigo |
| Iaith: | Inglês |
| Cyhoeddwyd: |
Dove Medical Press
2015
|
| Pynciau: | |
| Mynediad Ar-lein: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4455847/ https://ncbi.nlm.nih.gov/pubmed/26064072 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/IJWH.S69475 |
| Tagiau: |
Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!
|